As we and others have shown an important regulatory role for Trem2 and TREM2+ macrophages in the progression of NAFLD in mice [15], we next wanted to translate our findings into humans. This evidence concerns the gene TREM2 and metabolic dysfunction-associated steatotic liver disease.